SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-135935
Filing Date
2023-05-04
Accepted
2023-05-04 16:16:10
Documents
15
Period of Report
2023-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d301084d8k.htm   iXBRL 8-K 27509
2 EX-99.1 d301084dex991.htm EX-99.1 57288
7 GRAPHIC g301084g51x15.jpg GRAPHIC 14293
  Complete submission text file 0001193125-23-135935.txt   271306

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nuvb-20230504.xsd EX-101.SCH 4098
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nuvb-20230504_def.xml EX-101.DEF 13757
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvb-20230504_lab.xml EX-101.LAB 22937
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvb-20230504_pre.xml EX-101.PRE 14725
9 EXTRACTED XBRL INSTANCE DOCUMENT d301084d8k_htm.xml XML 5590
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

IRS No.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39351 | Film No.: 23888971
SIC: 2834 Pharmaceutical Preparations